- Approval Id
- 59076c6527766e07
- Drug Name
- Telfast Oral Suspension 6 mg/ml
- Product Name
- Telfast Oral Suspension 6 mg/ml
- Approval Number
- SIN14199P
- Approval Date
- 2012-07-20
- Registrant
- OPELLA HEALTHCARE SINGAPORE PTE. LTD.
- Licence Holder
- OPELLA HEALTHCARE SINGAPORE PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- SUSPENSION
- Dosage
- <p><strong>DOSAGE AND ADMINISTRATION</strong><br>
<u>Seasonal Allergic Rhinitis</u><br>
<em>Children 2 to 11 Years:</em> The recommended dose of TELFAST oral suspension is 30 mg twice daily.<br>
A dose of 30mg (5 mL) once daily is recommended as the starting dose in pediatric patients with decreased renal function <em>[see Clinical Pharmacology</em> – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em><em>]</em>.<br>
Shake bottle well, before each use.</p>
<p><u>Chronic Idiopathic Urticaria</u><br>
<em>Children 6 Months to 11 years:</em> The recommended dose of TELFAST oral suspension is 30 mg (5 mL) twice daily for patients 2 to 11 years of age and 15 mg (2.5 mL) twice daily for patients 6 months to less than 2 years of age. For pediatric patients with decreased renal function, the recommended starting doses of TELFAST oral suspension are 30 mg (5 mL) once daily for patients 2 to 11 years of age and 15 mg (2.5 mL) once daily for patients 6 months to less than 2 years of age <em>[see Clinical Pharmacology</em> – <em>please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information</em><em>]</em>.<br>
Shake bottle well, before each use.</p>
- Route Of Administration
- ORAL
- Indication Info
- <p><strong>INDICATIONS AND USAGE</strong></p>
<ul>
<li><p><strong>Seasonal Allergic Rhinitis</strong><br>
TELFAST is indicated for the relief of symptoms associated with seasonal allergic rhinitis in adults and children 2 years of age and older.</p></li>
<li><p><strong>Chronic Idiopathic Urticaria</strong><br>
TELFAST is indicated for treatment of uncomplicated skin manifestations of chronic idiopathic urticaria in adults and children 6 months of age and older.</p></li>
</ul>
- Contraindications
- <p><strong>CONTRAINDICATIONS</strong><br>
TELFAST oral suspension is contraindicated in patients with known hypersensitivity to fexofenadine and any of the ingredients of TELFAST. Rare cases of hypersensitivity reactions with manifestations such as angioedema, chest tightness, dyspnea, flushing and systemic anaphylaxis have been reported.</p>
- Atc Code
- R06AX26
- Atc Item Name
- fexofenadine
- Pharma Manufacturer Name
- OPELLA HEALTHCARE SINGAPORE PTE. LTD.
